Outcome of Board meeting held on 26-04-2025 for approval of audited financials of the company for the quarter and year ended on 31-03-2025 and appointment of Internal Auditors and Secretarial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Samsrita Labs Ltd met on April 26, 2025 and approved the audited financial results for Q4 and full year ended March 31, 2025. The company reported a loss of ₹8.70 lakhs in Q4 FY25 (vs ₹4.05 lakhs loss in Q4 FY24) and a full-year loss of ₹25.95 lakhs (vs ₹24.99 lakhs loss in FY24), with EPS of (₹0.18). Revenue from operations remains nil, while employee benefit expenses stood at ₹13.14 lakhs and other expenses at ₹12.67 lakhs for the year. Cash and cash equivalents dropped to ₹0.24 lakhs from ₹0.43 lakhs, and reserves & surplus worsened to (₹272.50) lakhs. The Board also appointed Tungala & Co. as Internal Auditors for FY25-26 and Manoj Parakh & Associates as Secretarial Auditors for a five-year term, subject to shareholder approval.
For shareholders, the key takeaway is another year of widening losses with no operational revenue, weakening reserves and shrinking cash balance — a negative signal on the company's going-concern trajectory. The auditor appointments are routine governance items and unlikely to move the stock on their own, though the secretarial auditor's 5-year tenure needs shareholder nod.